These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19053162)

  • 21. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond repeated-measures analysis of variance: advanced statistical methods for the analysis of longitudinal data in anesthesia research.
    Ma Y; Mazumdar M; Memtsoudis SG
    Reg Anesth Pain Med; 2012; 37(1):99-105. PubMed ID: 22189576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sample size in clinical trials with dichotomous endpoints: use of covariables.
    Choi SC
    J Biopharm Stat; 1998 Jul; 8(3):367-75. PubMed ID: 9741853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Group sequential methods for cluster randomization trials with binary outcomes.
    Zou GY; Donner A; Klar N
    Clin Trials; 2005; 2(6):479-87. PubMed ID: 16422308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Power and sample size for the S:T repeated measures design combined with a linear mixed-effects model allowing for missing data.
    Tango T
    J Biopharm Stat; 2017; 27(6):963-974. PubMed ID: 28319460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal design of longitudinal data analysis using generalized estimating equation models.
    Liu J; Colditz GA
    Biom J; 2017 Mar; 59(2):315-330. PubMed ID: 27878852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profile clustering in clinical trials with longitudinal and functional data methods.
    Gong H; Xun X; Zhou Y
    J Biopharm Stat; 2019; 29(3):541-557. PubMed ID: 30810454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sample size considerations for paired experimental design with incomplete observations of continuous outcomes.
    Zhu H; Xu X; Ahn C
    Stat Methods Med Res; 2019 Feb; 28(2):589-598. PubMed ID: 28956503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sample Size Estimation for Comparing Rates of Change in K-group Repeated Count Outcomes.
    Lou Y; Cao J; Ahn C
    Commun Stat Theory Methods; 2017; 46(22):11204-11213. PubMed ID: 30930527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A note on effective sample size for constructing confidence intervals for the difference of two proportions.
    Liu GF
    Pharm Stat; 2012; 11(2):163-9. PubMed ID: 22337507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small sample GEE estimation of regression parameters for longitudinal data.
    Paul S; Zhang X
    Stat Med; 2014 Sep; 33(22):3869-81. PubMed ID: 24797886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sample size calculations with multiplicity adjustment for longitudinal clinical trials with missing data.
    Lu K
    Stat Med; 2012 Jan; 31(1):19-28. PubMed ID: 22162151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Longitudinal Outcome Data with Missing Values in Total Knee Arthroplasty.
    Kang YG; Lee JT; Kang JY; Kim GH; Kim TK
    J Arthroplasty; 2016 Jan; 31(1):81-6. PubMed ID: 26248852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal allocation of sample sizes to multicenter clinical trials.
    Lai D; Chang KC; Rahbar MH; Moye LA
    J Biopharm Stat; 2013; 23(4):818-28. PubMed ID: 23786227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of multicenter clinical trials with very low event rates.
    Kim J; Troxel AB; Halpern SD; Volpp KG; Kahan BC; Morris TP; Harhay MO
    Trials; 2020 Nov; 21(1):917. PubMed ID: 33168073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of longitudinal clinical trials with missing data using multiple imputation in conjunction with robust regression.
    Mehrotra DV; Li X; Liu J; Lu K
    Biometrics; 2012 Dec; 68(4):1250-9. PubMed ID: 22994905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of number of subjects required for comparison of drug versus control in adaptive designs.
    Hu FF; Hu JH
    Ann Acad Med Singap; 2000 Sep; 29(5):565-9. PubMed ID: 11126689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sample size estimation for non-inferiority trials of time-to-event data.
    Crisp A; Curtis P
    Pharm Stat; 2008; 7(4):236-44. PubMed ID: 17583558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical considerations on design and analysis of bridging and multiregional clinical trials.
    Tsong Y
    J Biopharm Stat; 2012 Sep; 22(5):1078-80. PubMed ID: 22946952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.